Remove 2019 Remove Patients Remove Treatment
article thumbnail

Ask The Green Nurse: Puff with Caution: Safer Cannabinoid Options for Asthma Patients

The Cannigma

Why Smoking Cannabis Isn’t Suitable for Asthma Patients Cannabis smoke, like all smoke, contains irritants and toxins that can aggravate asthma symptoms. However, for asthma patients, even vaporization may trigger airway reactivity, making it less ideal as a long-term option. Vuolo et al.,

article thumbnail

Ask The Green Nurse: Why Do People Use Medical Cannabis? Top 3 Evidence-Based Reasons to Consider Plant Medicine

The Cannigma

Cannabis is not a universal cure, but for millions, it provides relief when conventional treatments fail. Ask any seasoned cannabis nurse or patient advocate, and you’ll likely hear powerful affirmations like: “Cannabis saved my life.” Chronic Pain Management Pain is the leading reason patients turn to medical cannabis.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Expanding Wellness Through ESA Services

Canna Care Docs

Whitman, co-founder of Naked Leaf (a CBD brand for people and pets acquired in 2019), noted that while CBD use for pets has been growing in the U.S. That’s why CMed is now offering ESA Certification Services , helping patients legally recognize their pet’s emotional support role. for years, international markets are now following suit.

article thumbnail

FDA Approves Ketamine Nasal Spray as First and Only Standalone Therapy for Treatment-Resistant Depression

Veriheal

In January, the US Food and Drug Administration (FDA) approved the Johnson & Johnson brand nasal spray, Spravato®, as the world’s first and only monotherapy for addressing treatment-resistant cases of major depressive disorder (MDD). However, doctors do not consider esketamine a first-line treatment for depression.

article thumbnail

Virginia: New Medical Cannabis Laws Take Effect July 1

NORML

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”

Law
article thumbnail

This app-guided psychedelic treatment works when antidepressants don’t

The Cannigma

Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment? Ketamine treatment for depression may be one of the biggest leaps forward in mental healthcare in decades.

article thumbnail

Pennsylvania: Marijuana possession arrests decline statewide

NORML

Preliminary data*, released on request from the Pennsylvania State Police Uniform Crime Reporting System, reveals that overall arrests for marijuana possession showed a decline in 2019. The new data shows 19,990 adults arrested for the same offense in 2019. Chris Goldstein, a writer and regional organizer for NORML, has gathered Pa.